DJIA 18,037.97 -42.17 -0.23%
NASDAQ 5,060.25 -31.84 -0.63%
S&P 500 2,108.92 -8.77 -0.41%
market minute promo

Mylan Inc. (NASDAQ: MYL)

71.72 -4.34 (-5.71%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

MYL $71.72 -5.71%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $75.40
Previous Close $76.06
Daily Range $71.21 - $75.40
52-Week Range $44.80 - $76.69
Market Cap $27.1B
P/E Ratio 32.50
Dividend (Yield) $0.00 (0.0%)
Volume 20,052,648
Average Daily Volume 12,475,801
Current FY EPS $4.16

Sector

Healthcare

Industry

Drug Makers

Mylan Inc. (MYL) Description

The Company develops, licenses, manufactures, markets and distributes generic, brand and branded generic pharmaceutical products and active pharmaceutical ingredients. Website: http://www.mylan.com/

News & Commentary Rss Feed

Why Mylan NV Is Suddenly in the Driver's Seat

Find out why Mylan's merger and acquisitions "triangle" has the generic drugmaker sitting pretty.

Benzinga's M&A Chatter for Monday April 27, 2015

Mylan Rejects Teva's Unsolicited Bid, While Teva Reiterates Its Original Offer

Perrigo Rejects Mylan's Offer Again, Cites Undervaluation - Analyst Blog

S&P 500 Movers: AMAT, FCX

Nasdaq 100 Movers: AMAT, TSLA

Mylan (MYL) Stock Declines Today After Board Unanimously Rejects Teva Offer

Teva Puts Forth Its Best Bid To Acquire Mylan

Teva Puts Forth Its Best Bid To Acquire Mylan

TEVA Acquisition Of Mylan Would Produce Generic Powerhouse

Deutsche Bank Boosts Mylan's Price Target On This Scenario

Midday Update: Positive Tech Earnings Fuel Nasdaq Rally But Blue-Chips Lag on Disappointing Durable

Midday Update: Positive Tech Earnings Fuel Nasdaq Rally But Blue-Chips Lag on Disappointing Durable Goods Orders

See More MYL News...

MYL's Top Competitors

MYL $71.72 (-5.71%)
Current stock: MYL
JNJ $100.58 (-0.49%)
Current stock: JNJ
NVS $103.91 (-0.35%)
Current stock: NVS
RHHBY $36.20 (-0.10%)
Current stock: RHHBY